| IPAD-DB ID | C01267 | 
| Name | Cyanidin-3-O-glucoside (Cy-3G) | 
| Category | Natural compounds | 
| 2D Structure | 
                             | 
                    
| 3D Structure | |
| Molecular Formula | C 2 1 H 2 1 O 1 1 + | 
| Molecular Weight | 449.4 g/mol | 
| IUPAC Name | (2S, 3R, 4S, 5S, 6R)-2-[2-(3, 4-dihydroxyphenyl)-5, 7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3, 4, 5-triol | 
| InChI | InChI=1S/C21H20O11/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8/h1-6, 16-19, 21-22, 27-29H, 7H2, (H3-, 23, 24, 25, 26)/p+1/t16-, 17-, 18+, 19-, 21-/m1/s1 | 
| InChIKey | RKWHWFONKJEUEF-GQUPQBGVSA-O | 
| Canonical SMILES | C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(C(O4)CO)O)O)O)O)O)O)O | 
| PubChem CID | 441667 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | 47705-70-4 | 
| Molecular Weight(Computed by SwissADME) | 449.38 | 
| Hac(Computed by SwissADME) | 32 | 
| Volume(Computed by ADMETlab 2.0) | 414.465 | 
| Density(Computed by ADMETlab 2.0) | 1.084 | 
| nRing(Computed by ADMETlab 2.0) | 4 | 
| MaxRing(Computed by ADMETlab 2.0) | 10 | 
| nHet(Computed by ADMETlab 2.0) | 11 | 
| fChar(Computed by ADMETlab 2.0) | 1 | 
| nRig(Computed by ADMETlab 2.0) | 23 | 
| Flexibility(Computed by ADMETlab 2.0) | 0.174 | 
| Stero Centers(Computed by ADMETlab 2.0) | 5 | 
| LogS(Computed by ADMETlab 2.0) | -3.544 | 
| LogD(Computed by ADMETlab 2.0) | 1.163 | 
| logP(Computed by ADMETlab 2.0) | 0.007 | 
| TPSA(Computed by SwissADME) | 193.44 | 
| Hbond Acceptor(Computed by SwissADME) | 11 | 
| Hbond Donor(Computed by SwissADME) | 8 | 
| Rotatable Bonds(Computed by SwissADME) | 4 | 
| GI Absorption(Computed by SwissADME) | Low | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No | 
| P-gp Substrate(Computed by SwissADME) | No | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | No | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | No | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -8.94 | 
| Lipinski(Computed by SwissADME) | 2 | 
| Ghose(Computed by SwissADME) | 0 | 
| Veber(Computed by SwissADME) | 1 | 
| Egan(Computed by SwissADME) | 1 | 
| Muegge(Computed by SwissADME) | 3 | 
| Bioavailability Score(Computed by SwissADME) | 0.17 |